(Q40437260)

English

The safety, pharmacokinetics, and anti-inflammatory effects of intratracheal recombinant human Clara cell protein in premature infants with respiratory distress syndrome

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 September 2017

The safety, pharmacokinetics, and anti-inflammatory effects of intratracheal recombinant human Clara cell protein in premature infants with respiratory distress syndrome (English)

1 reference

Europe PubMed Central

20 September 2017

0 references

0 references

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Carolyn R Levine

1

1 reference

Europe PubMed Central

20 September 2017

Ira H Gewolb

2

1 reference

Europe PubMed Central

20 September 2017

Kristen Allen

3

1 reference

Europe PubMed Central

20 September 2017

Richard W Welch

4

1 reference

Europe PubMed Central

20 September 2017

James M Melby

5

1 reference

Europe PubMed Central

20 September 2017

Simcha Pollack

6

1 reference

Europe PubMed Central

20 September 2017

Thomas Shaffer

7

1 reference

Europe PubMed Central

20 September 2017

Aprile L Pilon

8

1 reference

Europe PubMed Central

20 September 2017

Jonathan M Davis

9

1 reference

Europe PubMed Central

20 September 2017

language of work or name

0 references

publication date

17 March 2005

1 reference

Europe PubMed Central

20 September 2017

Pediatric Research

1 reference

Europe PubMed Central

20 September 2017

58

1 reference

Europe PubMed Central

20 September 2017

1

1 reference

Europe PubMed Central

20 September 2017

15-21

1 reference

Europe PubMed Central

20 September 2017

https://scigraph.springernature.com/pub.10.1203/01.pdr.0000156371.89952.35

0 references

Uteroglobin: a novel cytokine?

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000156371.89952.35

21 January 2018

Tissue-specific expression of the gene coding for human Clara cell 10-kD protein, a phospholipase A2-inhibitory protein

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000156371.89952.35

21 January 2018

Detection of a uteroglobin-like phospholipase A2 inhibitory protein in the circulation of rabbits.

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000156371.89952.35

21 January 2018

Human urinary protein 1: evidence for identity with the Clara cell protein and occurrence in respiratory tract and urogenital secretions

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000156371.89952.35

21 January 2018

Inhibition of phagocyte chemotaxis by uteroglobin, an inhibitor of blastocyst rejection.

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000156371.89952.35

21 January 2018

Uteroglobin is essential in preventing immunoglobulin A nephropathy in mice

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000156371.89952.35

21 January 2018

Altered pulmonary response to hyperoxia in Clara cell secretory protein deficient mice.

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000156371.89952.35

21 January 2018

Clara cell secretory protein modulates lung inflammatory and immune responses to respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000156371.89952.35

21 January 2018

Safety and efficacy of intratracheal recombinant human Clara cell protein in a newborn piglet model of acute lung injury.

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000156371.89952.35

21 January 2018

Stable, long-term bacterial production of soluble, dimeric, disulfide-bonded protein pharmaceuticals without antibiotic selection.

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000156371.89952.35

21 January 2018

In vivo measurements of changes in respiratory mechanics with age in mice deficient in surfactant protein D.

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000156371.89952.35

21 January 2018

New insights into the pathogenesis of pulmonary inflammation in preterm infants

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000156371.89952.35

21 January 2018

Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase.

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000156371.89952.35

21 January 2018

The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000156371.89952.35

21 January 2018

Early dexamethasone therapy in preterm infants: a follow-up study

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000156371.89952.35

21 January 2018

Identifiers

10.1203/01.PDR.0000156371.89952.35

1 reference

Europe PubMed Central

20 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40437260&oldid=2144462248"